News Sentiment

4588 sentiment intelligence

Oncolys BioPharma Inc. news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.

Chart Weekly report RSS feed
Weighted score 50 Balanced news tone 3 relevant articles
Exchange JPX Japan
Sector Healthcare Market context
Industry Biotechnology Read-through group
Latest close 2575.00 Week of 10 Jul 2026
Weighted tone 50/100

Balanced news tone

Market reaction Balanced read

News tone and price action are not far from neutral.

Primary event Market update

66/100 classification confidence.

Company focus 3

directly relevant articles

Source quality 0

high-authority source matches

Trend context Trend active

-3.9% over one week, +4.4% over four weeks, trend active, and materially above fair value.

Latest direct headline Neutral

Japan backs Oncolys virus therapy for esophageal cancer

Market Reaction

Balanced read

53/100 confidence

News tone and price action are not far from neutral.

Primary event Market update 66/100 classification
One-week reaction -3.9% Price reacting lower
Trend fit Trend active 4.4% over four weeks
Fair value 168.4% Materially above fair value

Sentiment Mix

Positive, neutral, negative

Weighted by relevance
Positive 0
Neutral 3
Negative 0

Relevance

Why the article matched

Direct first
Direct company coverage 3
Industry context 0
Sector context 0

Sources

Coverage mix

Publishers
BioWorld News 2
insights.citeline.com 1

Event Lens

What the news is about

Classified themes
Market update 2
Regulatory and legal 1

Sentiment Trail

Score over time

50 baseline
Above 50 Neutral zone Below 50

News Tape

Relevant headlines

Showing 1-3 of 3